Circ_0018814 promotes the osteogenic differentiation of mesenchymal stem cells in ankylosing spondylitis by regulating the miR-944/KLF4 axis
- 1Department of Rheumatology and Immunology, People’s Hospital of Ningxia Hui Autonomous Region（The Third Clinical Medicine College, Ningxia Medical University）, Ningxia Hui Autonomous Region, 750000 China
- 2Ningxia Key Laboratory of Precision Medicine for Systemic Autoimmune Diseases, Ningxia Hui Autonomous Region, 750000 China
Abstract
Ankylosing spondylitis (AS) is a chronic inflammatory disease primarily affecting the spine and sacroiliac joints. This study investigated the impact of circ_0018814 on the osteogenic differentiation of mesenchymal stem cells (MSCs) in AS through the regulation of the miR-944/KLF4 axis and to evaluate its potential role in the progression of AS. GSE203155 was used as an exploratory screening dataset to identify candidate circRNAs associated with osteogenic differentiation in AS-MSCs. Circ_0018814 expression was further evaluated in bone marrow samples and primary MSCs. The effects of circ_0018814 on osteogenic differentiation markers (ALP, RUNX2, COL1A1) in MSCs from AS patients were assessed using western blot, ALP assay, and alizarin red S staining. The targeting relationship between circ_0018814, KLF4, and miR-944 was confirmed through luciferase reporter and RNA immunoprecipitation assays. Fluorescence in situ hybridization was used for cellular localization. Further experiments in a murine AS model evaluated the impact of circ_0018814 on AS lesions and MSC differentiation. The results showed that overexpression of circ_0018814 significantly enhanced the expression of osteogenic markers ALP, RUNX2, and COL1A1, and promoted the osteogenic differentiation of MSCs. Additionally, circ_0018814 regulated KLF4 expression by targeting miR-944. Inhibition of miR-944 upregulated KLF4 expression and promoted osteogenic differentiation. In the AS mouse model, downregulation of circ_0018814 significantly alleviated spinal lesions, restored normal expression levels of miR-944 and KLF4, and reduced disease-related osteogenic changes. This study demonstrates that circ_0018814 plays an important role in the pathological progression of AS by regulating the miR-944/KLF4 axis. circ_0018814 may serve as a novel potential therapeutic target for AS, providing new insights for future treatment strategies. However, the in vivo findings should be interpreted cautiously because tail vein delivery of lentiviral constructs is not MSC-specific.
Supplementary Information: The online version contains supplementary material available at https://doi.org/10.1007/s10735-026-11019-3.
Related
- Curcumin promotes osteogenic differentiation of bone marrow mesenchymal stem cells via the miR-206/Hdac4 signaling axis
- Benzo(a)pyrene Exposure Suppressed Osteogenic and Adipogenic Differentiation of Human Bone Marrow-Derived Mesenchymal Stem Cells and Was Associated with Senescence-like Response
- HOTAIR regulates osteogenic–adipogenic differentiation imbalance through the miR-217/DKK1-mediated Wnt/β-catenin pathway in SONFH-BMSCs
- Mesenchymal Stem Cell-Derived Exosomes for Bone Regeneration: Modification Strategies and miRNA-Mediated Modulation of Osteogenic Signaling
- Adenine Promotes Osteogenic Differentiation and Suppresses Osteoclastogenesis
BibTeX
@article{chen2026circ0018814,
title = {{Circ_0018814 promotes the osteogenic differentiation of mesenchymal stem cells in ankylosing spondylitis by regulating the miR-944/KLF4 axis}},
author = {Xi Chen and Jing Xie and Yanju Li and Xu Chen and Yuanyuan Liu and Donggeng Guo},
journal = {Journal of Molecular Histology},
year = {2026},
month = nov,
doi = {10.1007/s10735-026-11019-3},
url = {https://doi.org/10.1007/s10735-026-11019-3},
note = {CC BY-NC-ND 4.0},
}
RIS
TY - JOUR
TI - Circ_0018814 promotes the osteogenic differentiation of mesenchymal stem cells in ankylosing spondylitis by regulating the miR-944/KLF4 axis
AU - Xi Chen
AU - Jing Xie
AU - Yanju Li
AU - Xu Chen
AU - Yuanyuan Liu
AU - Donggeng Guo
PY - 2026
DA - 2026/11/01
JO - Journal of Molecular Histology
DO - 10.1007/s10735-026-11019-3
UR - https://doi.org/10.1007/s10735-026-11019-3
AB - Ankylosing spondylitis (AS) is a chronic inflammatory disease primarily affecting the spine and sacroiliac joints. This study investigated the impact of circ_0018814 on the osteogenic differentiation of mesenchymal stem cells (MSCs) in AS through the regulation of the miR-944/KLF4 axis and to evaluate its potential role in the progression of AS. GSE203155 was used as an exploratory screening dataset to identify candidate circRNAs associated with osteogenic differentiation in AS-MSCs. Circ_0018814 expression was further evaluated in bone marrow samples and primary MSCs. The effects of circ_0018814 on osteogenic differentiation markers (ALP, RUNX2, COL1A1) in MSCs from AS patients were assessed using western blot, ALP assay, and alizarin red S staining. The targeting relationship between circ_0018814, KLF4, and miR-944 was confirmed through luciferase reporter and RNA immunoprecipitation assays. Fluorescence in situ hybridization was used for cellular localization. Further experiments in a murine AS model evaluated the impact of circ_0018814 on AS lesions and MSC differentiation. The results showed that overexpression of circ_0018814 significantly enhanced the expression of osteogenic markers ALP, RUNX2, and COL1A1, and promoted the osteogenic differentiation of MSCs. Additionally, circ_0018814 regulated KLF4 expression by targeting miR-944. Inhibition of miR-944 upregulated KLF4 expression and promoted osteogenic differentiation. In the AS mouse model, downregulation of circ_0018814 significantly alleviated spinal lesions, restored normal expression levels of miR-944 and KLF4, and reduced disease-related osteogenic changes. This study demonstrates that circ_0018814 plays an important role in the pathological progression of AS by regulating the miR-944/KLF4 axis. circ_0018814 may serve as a novel potential therapeutic target for AS, providing new insights for future treatment strategies. However, the in vivo findings should be interpreted cautiously because tail vein delivery of lentiviral constructs is not MSC-specific. Supplementary Information: The online version contains supplementary material available at https://doi.org/10.1007/s10735-026-11019-3.
SN - 1567-2379
SN - 1567-2387
ER -